BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 27551808)

  • 1. Vaccine adjuvants: Why and how.
    Christensen D
    Hum Vaccin Immunother; 2016 Oct; 12(10):2709-2711. PubMed ID: 27551808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens.
    Perrie Y; Mohammed AR; Kirby DJ; McNeil SE; Bramwell VW
    Int J Pharm; 2008 Dec; 364(2):272-80. PubMed ID: 18555624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unmet needs in modern vaccinology: adjuvants to improve the immune response.
    Leroux-Roels G
    Vaccine; 2010 Aug; 28 Suppl 3():C25-36. PubMed ID: 20713254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine adjuvants: smart components to boost the immune system.
    Bastola R; Noh G; Keum T; Bashyal S; Seo JE; Choi J; Oh Y; Cho Y; Lee S
    Arch Pharm Res; 2017 Nov; 40(11):1238-1248. PubMed ID: 29027637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What are the limits of adjuvanticity?
    Del Giudice G; Podda A; Rappuoli R
    Vaccine; 2001 Oct; 20 Suppl 1():S38-41. PubMed ID: 11587808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and selection of vaccine adjuvants: animal models and human trials.
    Alving CR
    Vaccine; 2002 May; 20 Suppl 3():S56-64. PubMed ID: 12184368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overview of adjuvants utilized in prophylactic vaccine formulation as immunomodulators.
    Chauhan N; Tiwari S; Iype T; Jain U
    Expert Rev Vaccines; 2017 May; 16(5):491-502. PubMed ID: 28285554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The development and use of vaccine adjuvants.
    Edelman R
    Mol Biotechnol; 2002 Jun; 21(2):129-48. PubMed ID: 12059113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity.
    Marciani DJ
    Drug Discov Today; 2003 Oct; 8(20):934-43. PubMed ID: 14554157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine adjuvants.
    Macy DW
    Semin Vet Med Surg Small Anim; 1997 Aug; 12(3):206-11. PubMed ID: 9283246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvants in veterinary vaccines: modes of action and adverse effects.
    Spickler AR; Roth JA
    J Vet Intern Med; 2003; 17(3):273-81. PubMed ID: 12774966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current adjuvants and new perspectives in vaccine formulation.
    Montomoli E; Piccirella S; Khadang B; Mennitto E; Camerini R; De Rosa A
    Expert Rev Vaccines; 2011 Jul; 10(7):1053-61. PubMed ID: 21806399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of adjuvants in retroviral vaccines.
    Vogel FR
    Int J Immunopharmacol; 1995 Feb; 17(2):85-90. PubMed ID: 7657411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Status and future prospects of lipid-based particulate delivery systems as vaccine adjuvants and their combination with immunostimulators.
    Nordly P; Madsen HB; Nielsen HM; Foged C
    Expert Opin Drug Deliv; 2009 Jul; 6(7):657-72. PubMed ID: 19538037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in vaccine adjuvants.
    Schijns VE; Lavelle EC
    Expert Rev Vaccines; 2011 Apr; 10(4):539-50. PubMed ID: 21506650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel vaccines and adjuvant systems: the utility of animal models for predicting immunogenicity in humans.
    Davis HL
    Hum Vaccin; 2008; 4(3):246-50. PubMed ID: 18382138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunologic adjuvants for modern vaccine formulations.
    Vogel FR
    Ann N Y Acad Sci; 1995 May; 754():153-60. PubMed ID: 7625649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvants for veterinary vaccines--types and modes of action.
    Gerdts V
    Berl Munch Tierarztl Wochenschr; 2015; 128(11-12):456-63. PubMed ID: 26697712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel lipid nanoparticle adjuvant significantly enhances B cell and T cell responses to sub-unit vaccine antigens.
    Swaminathan G; Thoryk EA; Cox KS; Meschino S; Dubey SA; Vora KA; Celano R; Gindy M; Casimiro DR; Bett AJ
    Vaccine; 2016 Jan; 34(1):110-9. PubMed ID: 26555351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune modulators with defined molecular targets: cornerstone to optimize rational vaccine design.
    Ebensen T; Guzmán CA
    Hum Vaccin; 2008; 4(1):13-22. PubMed ID: 18376145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.